John Rothman Selected Research

Vaccines

1/2013	Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy.
12/2012	Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer.
6/2009	The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Rothman Research Topics

Disease

5	Neoplasms (Cancer) 05/2013 - 01/2012
1	Pheochromocytoma 10/2019
1	Prostatic Neoplasms (Prostate Cancer) 12/2012
1	Infections 01/2012
1	Carcinoma (Carcinomatosis) 06/2009

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 01/2013 - 06/2009
2	AntigensIBA 05/2013 - 01/2013
1	alpha-Methyltyrosine (Metirosine)FDA Link 10/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2013
1	LigandsIBA 01/2013
1	CytokinesIBA 12/2012

Therapy/Procedure

5	Immunotherapy 05/2013 - 01/2012
1	Radiotherapy 12/2012
1	Therapeutics 12/2012